Recommendations for the Use of Abatacept in Patients with rheumatoid Arthritis

被引：0
|
作者：
Gaubitz, M. [1 ]
Krueger, K. [2 ]
Haas, J. -P. [3 ]
机构：
[1] WWU Munster, Akad Manuelle Therapie, Munster, Germany
[2] Praxiszentrum, D-81541 Munich, Germany
[3] Kinderklin Garmisch Partenkirchen, Deutsch Zentrum Kinder & Jugendrheumatol, Garmisch Partenkirchen, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2014年 / 73卷 / 10期
关键词：
JUVENILE IDIOPATHIC ARTHRITIS; COSTIMULATION MODULATOR ABATACEPT; LONG-TERM SAFETY; INADEQUATE RESPONSE; DOUBLE-BLIND; PHASE IIIB; SUBCUTANEOUS ABATACEPT; BIOLOGICAL AGENTS; GERMAN SOCIETY; AIM TRIAL;
D O I：
10.1007/s00393-014-1373-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：942 / 949
页数：8
相关论文
共 50 条
  • [21] THE EFFECT OF ABATACEPT ON CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Borisova, M. A.
    Lukina, G. V.
    Sigidin, Y.
    Luchihina, E. L.
    Karateev, D. E.
    Novikov, A.
    Alexandrova, E.
    Aronova, E.
    Glukhova, S.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 576 - 576
  • [22] Characteristics of Rheumatoid Arthritis Patients Initiating Abatacept Therapy
    Thyagarajan, Veena
    Simon, Teresa A.
    Liu, Nan
    Lin, Nancy D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 470 - 471
  • [23] Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients
    Takahashi, Nobunori
    Kojima, Toshihisa
    Terabe, Kenya
    Kaneko, Atsushi
    Kida, Daihei
    Hirano, Yuji
    Fujibayashi, Takayoshi
    Yabe, Yuichiro
    Takagi, Hideki
    Oguchi, Takeshi
    Miyake, Hiroyuki
    Kato, Takefumi
    Fukaya, Naoki
    Ishikawa, Hisato
    Hayashi, Masatoshi
    Tsuboi, Seiji
    Kato, Daizo
    Funahashi, Koji
    Matsubara, Hiroyuki
    Hattori, Yosuke
    Hanabayashi, Masahiro
    Hirabara, Shinya
    Yoshioka, Yutaka
    Ishiguro, Naoki
    MODERN RHEUMATOLOGY, 2013, 23 (05) : 904 - 912
  • [24] Abatacept in clinical practice: Outcome in patients with rheumatoid arthritis
    Singh, Vijay
    Mishra, Richa
    Pritchard, Charles H.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4282 - 4282
  • [25] SEARCHING PREDICTORS OF ABATACEPT EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Borisova, M.
    Lukina, G.
    Sigidin Y A, Y.
    Aronova, E.
    Luchihina, E.
    Karateev, D.
    Novikov, A.
    Alexandrova, E.
    Cherkasova, M.
    Glukhova, S.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1312 - 1312
  • [26] Clinical effectiveness of baricitinib and abatacept in patients with rheumatoid arthritis
    Asai, Shuji
    Takahashi, Nobunori
    Terabe, Kenya
    Yoshioka, Yutaka
    Kojima, Toshihisa
    Kobayakawa, Tomonori
    Sobue, Yasumori
    Watanabe, Tatsuo
    Hirano, Yuji
    Kanayama, Yasuhide
    Kato, Takefumi
    Hanabayashi, Masahiro
    Suzuki, Mochihito
    Imagama, Shiro
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (11)
  • [27] Abatacept Use After Failure of Multiple Biologic Agents in Patients With Severe Rheumatoid Arthritis
    Hazlewood, Glen S.
    Barnabe, Cheryl
    Barr, Susan G.
    Martin, Liam
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2012, 18 (08) : 416 - 418
  • [28] Abatacept and the Treatment of Rheumatoid Arthritis
    Garcia Llorente, Jose Francisco
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2008, 30 : 25 - 26
  • [29] Abatacept (Orencia) for rheumatoid arthritis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1229): : 17 - 18
  • [30] Abatacept in the treatment of rheumatoid arthritis
    Todd, D. J.
    Costenbader, K. H.
    Weinblatt, M. E.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (03) : 494 - 500
12345